Anesth Analg 2006;102:91-97
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000184825.65124.24
ANESTHETIC PHARMACOLOGY
Pharmacokinetic-Pharmacodynamic Modeling the Hypnotic Effect of Sevoflurane Using the Spectral Entropy of the Electroencephalogram
Ian D. H. McKay, MBChB*,
Logan J. Voss, PhD ,
James W. Sleigh, MD, MBChB, FANZCA*,
John P. Barnard, MBChB, FANZCA*, and
Ewa K. Johannsen, MBBCh*
*Department of Anaesthesia, Waikato Hospital, New Zealand; Department of Anaesthesiology, University of Auckland, New Zealand
Address correspondence and reprint requests to Logan J Voss, c/- Intensive Care Department, Waikato Hospital, P.O. Box 3200, Hamilton, New Zealand. Address e-mail to VossL{at}waikatodhb.govt.nz.
Spectral entropy is a new electroencephalogram (EEG)-derived parameter that may be used to model the pharmacokinetic-pharmacodynamic (PKPD) effects of general anesthetics. In the present study we sought to derive a PKPD model of the relationship between sevoflurane concentration and spectral entropy of the EEG. We collected spectral entropy data during increasing and decreasing sevoflurane anesthesia from 20 patients. The first cycle consisted of induction and lightening phases with no supplemental medications. An effect-site compartment and inhibitory Emax model described the relation between sevoflurane concentration and spectral entropy. PKPD parameters were derived from the full cycle and separately from the increasing and decreasing stages. The second anesthetic cycle consisted of a redeepening phase only and included airway manipulation and routinely administered adjunctives. PKPD data obtained from the first cycle were used to predict second cycle entropy changes. There was a consistent relationship between effect-site sevoflurane concentration and spectral entropy (median absolute weighted residual = 11.6%). For complete first-cycle response entropy (mean ± sd): T1/2 Keo = 2.4 ± 1.5 min, = 5.9 ± 2.3, EC50 = 1.7 ± 0.3. We found significant differences between values when the sevoflurane concentration was increasing (61.1 ± 55.2) compared with the decreasing part of the cycle (5.7 ± 2.8). Above an effect-site concentration of 3%, spectral entropy of the EEG is unresponsive to further increases in sevoflurane concentration. The effect-compartment inhibitory Emax model accurately describes the relation between sevoflurane concentration and spectral entropy of the EEG. Spectral entropy decreases with increasing sevoflurane concentrations up to 3%. The steepness of the dose-response curve varies between phases of increasing and decreasing anesthetic concentrations.
This article has been cited by other articles:

|
 |

|
 |
 
C. Bennett, L. J. Voss, J. P. M. Barnard, and J. W. Sleigh
Practical Use of the Raw Electroencephalogram Waveform During General Anesthesia: The Art and Science
Anesth. Analg.,
August 1, 2009;
109(2):
539 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Olofsen, J. W. Sleigh, and A. Dahan
Permutation entropy of the electroencephalogram: a measure of anaesthetic drug effect
Br. J. Anaesth.,
December 1, 2008;
101(6):
810 - 821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Voss, J. W. Sleigh, J. P. M. Barnard, and H. E. Kirsch
The Howling Cortex: Seizures and General Anesthetic Drugs
Anesth. Analg.,
November 1, 2008;
107(5):
1689 - 1703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Barnard, C. Bennett, L. J. Voss, and J. W. Sleigh
Can anaesthetists be taught to interpret the effects of general anaesthesia on the electroencephalogram? Comparison of performance with the BIS and spectral entropy
Br. J. Anaesth.,
October 1, 2007;
99(4):
532 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. C. Lerou and J. Mourisse
Applying a physiological model to quantify the delay between changes in end-expired concentrations of sevoflurane and bispectral index
Br. J. Anaesth.,
August 1, 2007;
99(2):
226 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|